Aug 24, 2021
2:1
For every share held, investors received 2. The price per share adjusted from $101300.00 to $50650.00.
The split itself did not change the total investment value.
Aptabio Therapeutics, Inc. (KRX:293780) operates in the Pharmaceuticals: major industry.
Aptabio Therapeutics, Inc. company overviewAptabio Therapeutics, Inc.'s most recent stock split was on August 24, 2021. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Aptabio Therapeutics, Inc. has split its stock once. This history records one forward split, on August 24, 2021.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Aptabio Therapeutics, Inc.'s 2-for-1 split on August 24, 2021, every share became 2 shares.
Aptabio Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on August 24, 2021, 5 years ago. Companies announce splits in advance, and any new KRX:293780 split will appear on this page.
Already premium?